Microbiome

IP protection to support sustainable commercial development of microbiome-targeting applications. Discovering the influence of microorganisms on health, disease and wellbeing.

Microbiome targeting technology is a rapidly emerging, complex sector which improves human, animal, and crop health and well-being. Having actively advised on a full-range of IP matters involving manipulation and analysis of microbiomes for almost two decades, HGF has one of the most experienced teams in this area throughout Europe.  

Specialising in therapeutic, diagnostic, nutraceutical, cosmetic and agricultural application, as well as related bioinformatics-powered innovations, the team is well versed in the challenges and opportunities for protecting and commercialising the whole spectrum of microbiome-related inventions, and assists the full range of microbiome-focused companies in developing robust IP strategies, including IP protection, freedom to operate, licensing, European patent opposition and litigation strategies.

Latest updates

Event - 8th-9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 29th November 2022

LSPN Europe 2022

HGF is a silver sponsor of LSPN Europe 2022 on 29th November in London. This event will explore some of the biggest challenges facing the Life Sciences Patent Community right now …

Event details

Food technology companies and investors - the value of IP landscape analysis

Case study – alt fat innovation Many companies and investors are aware of the importance of identifying and protecting their innovations, and in particular of the importance of obtaining patents …

Read article
Event - 22nd September 2022

BioCap Conference 2022

HGF is a gold sponsor at the BioCap Conference 2022. The conference will be held on Thursday 22 September at the Alderley Park Conference Centre. It connects life sciences businesses, …

Event details

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 23rd March 2022

HGF webinar: Getting your first filing right

HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …

Event details

The Microbiome Times: ELIGO v SNIPR: a reflection on IP strategies in a competitive environment

HGF Partner and Patent Attorney Craig Thomson and Patent Director Dr Jennifer Bailey write an article for The Microbiome Times on ELIGO v SNIPR: a reflection on IP strategies in …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our microbiome specialists.